Litigation
thumbnail
Supplement RegulationsFDA delays substantive response to NMN petitionFDA delays substantive response to NMN petition
Citing “competing agency priorities,” the Food and Drug Administration said in a recent letter it has not reached a substantive decision on a citizen petition pertaining to NMN in dietary supplement products.
Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.